Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ray R. Arthur is active.

Publication


Featured researches published by Ray R. Arthur.


The Lancet | 2000

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

Christina Frank; Mostafa K. Mohamed; G. Thomas Strickland; Daniel Lavanchy; Ray R. Arthur; Laurence S. Magder; Taha El Khoby; Yehia Abdel-Wahab; El Said Aly Ohn; Wagida A. Anwar; Ismail Sallam

BACKGROUND The population of Egypt has a heavy burden of liver disease, mostly due to chronic infection with hepatitis C virus (HCV). Overall prevalence of antibody to HCV in the general population is around 15-20%. The risk factor for HCV transmission that specifically sets Egypt apart from other countries is a personal history of parenteral antischistosomal therapy (PAT). A review of the Egyptian PAT mass-treatment campaigns, discontinued only in the 1980s, show a very high potential for transmission of blood-borne pathogens. We examine the relative importance of PAT in the spread of HCV in Egypt. METHODS The degree of exposure to PAT by cohort was estimated from 1961-86 Ministry of Health data. A cohort-specific exposure index for PAT was calculated and compared with cohort-specific HCV prevalence rates in four regions. FINDINGS HCV prevalence was calculated for 8499 Egyptians aged 10-50 years. A significant association between seroprevalence of antibodies to HCV and the exposure index (1.31 [95% CI 1.08-1.59]; p=0.007) was identified across four different regions. In all regions cohort-specific HCV prevalence was lowest in children and young adults than in older cohorts. These lower prevalence rates coincided with the gradual and final replacement of PAT with oral antischistosomal drugs at different points in time in the four regions. INTERPRETATION The data suggest that PAT had a major role in the spread of HCV throughout Egypt. This intensive transmission established a large reservoir of chronic HCV infection, responsible for the high prevalence of HCV infection and current high rates of transmission. Egypts mass campaigns of PAT may represent the worlds largest iatrogenic transmission of blood-borne pathogens.


Emerging Infectious Diseases | 2002

An Outbreak of Rift Valley Fever in Northeastern Kenya, 1997-98

Christopher W. Woods; Adam Karpati; Thomas Grein; Noel D. McCarthy; Peter Gaturuku; Eric Muchiri; Lee M. Dunster; Alden Henderson; Ali S. Khan; Robert Swanepoel; Isabelle Bonmarin; Louise Martin; Philip Mann; Bonnie L. Smoak; Michael Ryan; Thomas G. Ksiazek; Ray R. Arthur; Andre Ndikuyeze; Naphtali N. Agata; Clarence J. Peters

In December 1997, 170 hemorrhagic fever-associated deaths were reported in Carissa District, Kenya. Laboratory testing identified evidence of acute Rift Valley fever virus (RVFV). Of the 171 persons enrolled in a cross-sectional study, 31(18%) were anti-RVFV immunoglobulin (Ig) M positive. An age-adjusted IgM antibody prevalence of 14% was estimated for the district. We estimate approximately 27,500 infections occurred in Garissa District, making this the largest recorded outbreak of RVFV in East Africa. In multivariate analysis, contact with sheep body fluids and sheltering livestock in one’s home were significantly associated with infection. Direct contact with animals, particularly contact with sheep body fluids, was the most important modifiable risk factor for RVFV infection. Public education during epizootics may reduce human illness and deaths associated with future outbreaks.


BMC Public Health | 2010

U.S. Government engagement in support of global disease surveillance

Rebecca L Katz; Leana M López; Joseph Annelli; Ray R. Arthur; Dennis Carroll; Leonard W Chapman; Kenneth Cole; Daniel L Lowe; Gary Resnick; Kevin L. Russell

Global cooperation is essential for coordinated planning and response to public health emergencies, as well as for building sufficient capacity around the world to detect, assess and respond to health events. The United States is committed to, and actively engaged in, supporting disease surveillance capacity building around the world. We recognize that there are many agencies involved in this effort, which can become confusing to partner countries and other public health entities. This paper aims to describe the agencies and offices working directly on global disease surveillance capacity building in order to clarify the United States Government interagency efforts in this space.


Emerging Health Threats Journal | 2010

Landscape of international event-based biosurveillance

David M. Hartley; Noele P. Nelson; Ronald A. Walters; Ray R. Arthur; Roman Yangarber; Lawrence C. Madoff; Jens P. Linge; Abla Mawudeku; Nigel Collier; John S. Brownstein; Germain Thinus; Nigel Lightfoot

Event-based biosurveillance is a scientific discipline in which diverse sources of data, many of which are available from the Internet, are characterized prospectively to provide information on infectious disease events. Biosurveillance complements traditional public health surveillance to provide both early warning of infectious disease events and situational awareness. The Global Health Security Action Group of the Global Health Security Initiative is developing a biosurveillance capability that integrates and leverages component systems from member nations. This work discusses these biosurveillance systems and identifies needed future studies.


Clinical Microbiology and Infection | 2013

An overview of internet biosurveillance.

David M. Hartley; Noele P. Nelson; Ray R. Arthur; Philippe Barboza; Nigel Collier; Nigel Lightfoot; Jens P. Linge; E van der Goot; Abla Mawudeku; Lawrence C. Madoff; Laetitia Vaillant; Ronald A. Walters; Roman Yangarber; Jas Mantero; Courtney D. Corley; John S. Brownstein

Internet biosurveillance utilizes unstructured data from diverse web-based sources to provide early warning and situational awareness of public health threats. The scope of source coverage ranges from local media in the vernacular to international media in widely read languages. Internet biosurveillance is a timely modality that is available to government and public health officials, healthcare workers, and the public and private sector, serving as a real-time complementary approach to traditional indicator-based public health disease surveillance methods. Internet biosurveillance also supports the broader activity of epidemic intelligence. This overview covers the current state of the field of Internet biosurveillance, and provides a perspective on the future of the field.


Emerging Health Threats Journal | 2013

What We Are Watching—five top global infectious disease threats, 2012: a perspective from CDC’s Global Disease Detection Operations Center

Kira A. Christian; Kashef Ijaz; Scott F. Dowell; Catherine Chow; Rohit A. Chitale; Joseph S. Bresee; Eric D. Mintz; Mark A. Pallansch; Steven G. F. Wassilak; Eugene McCray; Ray R. Arthur

Disease outbreaks of international public health importance continue to occur regularly; detecting and tracking significant new public health threats in countries that cannot or might not report such events to the global health community is a challenge. The Centers for Disease Control and Prevention’s (CDC) Global Disease Detection (GDD) Operations Center, established in early 2007, monitors infectious and non-infectious public health events to identify new or unexplained global public health threats and better position CDC to respond, if public health assistance is requested or required. At any one time, the GDD Operations Center actively monitors approximately 30–40 such public health threats; here we provide our perspective on five of the top global infectious disease threats that we were watching in 2012: (1) avian influenza A (H5N1), (2) cholera, (3) wild poliovirus, (4) enterovirus-71, and (5) extensively drug-resistant tuberculosis.


Emerging Infectious Diseases | 2012

International Health Regulations—What Gets Measured Gets Done

Kashef Ijaz; Eric Kasowski; Ray R. Arthur; Frederick J. Angulo; Scott F. Dowell

Focus on goals and metrics for 4 core capacities illustrates 1 approach to implementing IHR.


Global Public Health | 2014

The Global Outbreak Alert and Response Network

John S. Mackenzie; Patrick Drury; Ray R. Arthur; Michael Ryan; Thomas Grein; Raphael Slattery; Sameera Suri; Christine Tiffany Domingo; Armand Bejtullahu

The Global Outbreak Alert and Response Network (GOARN) was established in 2000 as a network of technical institutions, research institutes, universities, international health organisations and technical networks willing to contribute and participate in internationally coordinated responses to infectious disease outbreaks. It reflected a recognition of the need to strengthen and coordinate rapid mobilisation of experts in responding to international outbreaks and to overcome the sometimes chaotic and fragmented operations characterising previous responses. The network partners agreed that the World Health Organization would coordinate the network and provide a secretariat, which would also function as the operational support team. The network has evolved to comprise 153 institutions/technical partners and 37 additional networks, the latter encompassing a further 355 members and has been directly involved in 137 missions to 79 countries, territories or areas. Future challenges will include supporting countries to achieve the capacity to detect and respond to outbreaks of international concern, as required by the International Health Regulations (2005). GOARNs increasing regional focus and expanding geographic composition will be central to meeting these challenges. The paper summarises some of networks achievements over the past 13 years and presents some of the future challenges.


American Journal of Transplantation | 2014

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014

Stephanie R. Bialek; Donna Allen; Francisco Alvarado-Ramy; Ray R. Arthur; Arunmozhi Balajee; David M. Bell; Susan Best; Carina Blackmore; Lucy Breakwell; Andrew Cannons; Clive Brown; Martin S. Cetron; Nora Chea; Christina Chommanard; Nicole J. Cohen; Craig Conover; Antonio Crespo; Jeanean Creviston; Aaron T. Curns; Rebecca M. Dahl; Stephanie Dearth; Alfred DeMaria; Fred Echols; Dean D. Erdman; Daniel R. Feikin; Mabel Frias; Susan I. Gerber; Reena Gulati; Christa Hale; Lia M. Haynes

Since mid-March 2014, the frequency with which cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection have been reported has increased, with the majority of recent cases reported from Saudi Arabia and United Arab Emirates (UAE). In addition, the frequency with which travel-associated MERS cases have been reported and the number of countries that have reported them to the World Health Organization (WHO) have also increased. The first case of MERS in the United States, identified in a traveler recently returned from Saudi Arabia, was reported to CDC by the Indiana State Department of Health on May 1, 2014, and confirmed by CDC on May 2. A second imported case of MERS in the United States, identified in a traveler from Saudi Arabia having no connection with the first case, was reported to CDC by the Florida Department of Health on May 11, 2014. The purpose of this report is to alert clinicians, health officials, and others to increase awareness of the need to consider MERS-CoV infection in persons who have recently traveled from countries in or near the Arabian Peninsula. This report summarizes recent epidemiologic information, provides preliminary descriptions of the cases reported from Indiana and Florida, and updates CDC guidance about patient evaluation, home care and isolation, specimen collection, and travel as of May 13, 2014.


Emerging Infectious Diseases | 2012

Assessment of Public Health Events through International Health Regulations, United States, 2007–2011

Katrin S. Kohl; Ray R. Arthur; Ralph O’Connor; Jose Fernandez

People and goods travel rapidly around the world, and so do infectious organisms. Sometimes a disease has already become widespread before it is detected and reported, which makes control efforts much more difficult. In response to this threat, the World Health Assembly enacted International Health Regulations that require participating countries to report public health events of international concern to the World Health Organization within 72 hours of detection. These health regulations went into effect in 2007 for all WHO Member States including the United States. By December 2011, 24 events reported by the United States were posted on a secure WHO web site, 12 of which were associated with influenza. Others reported were salmonellosis outbreaks, botulism, E. coli infections, Guillain-Barré syndrome, contaminated heparin, Lassa fever, an oil spill, and typhoid fever. International Health Regulations have improved global connectivity through rapid information exchange and increased awareness of threatening situations.

Collaboration


Dive into the Ray R. Arthur's collaboration.

Top Co-Authors

Avatar

David M. Hartley

Georgetown University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Noele P. Nelson

Georgetown University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Ronald A. Walters

Pacific Northwest National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Francisco Alvarado-Ramy

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Frederick J. Angulo

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lawrence C. Madoff

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Martin S. Cetron

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nigel Collier

National Institute of Informatics

View shared research outputs
Researchain Logo
Decentralizing Knowledge